|
Pediatric intensive care management in coronavirus infection-19
Namita Ravikumar1, Manu Sundaram2, Utpal Bhalala3, Dhiren Gupta4, Arun Bansal1
1 Department of Pediatrics, Division of Pediatric Critical Care, Advanced Pediatrics Centre, Postgraduate Institute of Medical Education and Research, Chandigarh, India
2 Division of Critical Care Medicine, Sidra Medicine; Department of Pediatrics, Weill Cornell Medicine, Doha, Qatar
3 Department of Pediatrics, The Children's Hospital of San Antonio; Department of Pediatrics, Baylor College of Medicine, San Antonio, Texas, USA
4 Department of Pediatric Critical Care, Sir Ganga Ram Hospital, New Delhi, India
Correspondence Address:
Dr. Arun Bansal
Department of Pediatrics, Division of Pediatric Critical Care, Advanced Pediatrics Centre, Postgraduate Institute of Medical Education and Research, Chandigarh - 160 012
India
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/JPCC.JPCC_77_20
|
|
Coronovirus-19 disease (CVOID-19) caused by severe acute respiratory syndrome-CoV2 has more than affected 3 million people worldwide, accounting for one of the largest pandemics known to humankind. Originating in China and traveling all across the globe, it spreads by droplets and fomites. Cohort intensive care units have been set up to manage critically ill CVOID-19 patients requiring organ support. Respiratory support, including low and high-flow oxygen devices, noninvasive and invasive ventilatory support have been used in the management of patients with severe acute respiratory illness. Aerosol generating procedures pose a high risk of transmission to health-care workers and need strict infection control practices and the use of personal protective equipment. Various anti-viral drugs have been tried, but there is inadequate evidence to recommend their routine use.
|
